# Rexis Biotech Inc. — Form C (Regulation Crowdfunding)

Rexis Biotech Inc. of Las Vegas, NV filed a Form C (Regulation Crowdfunding) with the SEC on 2023-12-08. Target raise $50K, up to $1.2M. Offered through Wefunder Portal LLC.

## Offering

- Filed: 2023-12-08
- Form: C
- Accession: 0001670254-23-001115
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Preferred Stock
- Securities offered: 44,248
- Price: $1.2500
- Deadline: 2024-04-29
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503

## Issuer

- CIK: 0002000970
- Website: https://www.rexissystems.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2022-01-24
- Address: 4364 E. Craig Rd, Las Vegas, NV, 89115
- Employees: 7

## Financials (as filed)

- Total assets (most recent): $19
- Cash (most recent): $19
- Revenue (most recent): $191K
- Net income (most recent): $-76

## People (3)

| Name | Role | Location |
| --- | --- | --- |
| Keith Bushfield | CEO | Pompano Beach, FL |
| Daniel R Wittmers | Executive Vice President | Pompano Beach, FL |
| Simon Selkrig | CFO | Pompano Beach, FL |

## Reg CF filing history (2)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2025-04-14](https://search.stillhousedata.com/formc/0002000970-25-000001) | C-AR | — | — |

## More

- [CIK 2000970 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2000970&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001670254-23-001115.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.